2015
DOI: 10.1016/j.jpba.2015.05.024
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous analysis of d-alanine, d-aspartic acid, and d-serine using chiral high-performance liquid chromatography-tandem mass spectrometry and its application to the rat plasma and tissues

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
35
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 63 publications
(38 citation statements)
references
References 39 publications
2
35
0
1
Order By: Relevance
“…As already demonstrated, the LOD for acidic amino acid by MS analysis was 100 times lower than that by HPLC-UV method and it was much lower for other amino acids [26]. The LOD values recorded by our MRM method resulted to be in perfect agreement, and even lower in some cases, with LODs measured in other LC-MS/MS analyses of d -amino acids in biological samples [3841]. Comparable LOD of a few ppb was achieved also by coupling of fluorescence-based detection to chiral columns e .…”
Section: Discussionsupporting
confidence: 71%
“…As already demonstrated, the LOD for acidic amino acid by MS analysis was 100 times lower than that by HPLC-UV method and it was much lower for other amino acids [26]. The LOD values recorded by our MRM method resulted to be in perfect agreement, and even lower in some cases, with LODs measured in other LC-MS/MS analyses of d -amino acids in biological samples [3841]. Comparable LOD of a few ppb was achieved also by coupling of fluorescence-based detection to chiral columns e .…”
Section: Discussionsupporting
confidence: 71%
“…Such a measurement needs careful experimental design, appropriate analytical techniques and proper execution in order to be confident in differentiating D-serine from other amino acids and from its L-enantiomer in biological samples. Analytical methods have matured, and we now have an array of techniques ranging from biosensors, [25][26][27] high pressure liquid chromatography (HPLC) [28][29][30] and LC/ LC 31 to LC/mass spectrometry 32,33 or capillary electrophoresis-laser-induced fluorescence (CE-LIF) [34][35][36] with well described protocols to detect and measure D-AAs (including D-serine) even at very low levels in complex matrices like biological samples. Despite the availability of multiple approaches to confirm D-serine, analysis of recent publications suggests that this D-AA was not always quantified with the controls that are outlined in Box 1 and Figure 1.…”
Section: Detecting D -Serine Properly With Analytical Methods: That Imentioning
confidence: 99%
“…However, current RgDAAO-based biosensors also detect most neutral D-AAs, including D-alanine, and might non-specifically oxidize other unexpected biological substances. Although D-alanine levels in the brain and in particular the hippocampus are much lower than those of D-serine, 29,31,32 the maximal activity and the catalytic efficiency of RgDAAO for D-alanine is 1.7-and 30 times higher than those for D-serine, 54 so it is conceivable that DAAO-based biosensors could also detect trace amounts of D-alanine which is also known to act as a co-agonist for NMDARs. Finally, it is also important to note that the commercial RgDAAO based biosensors are also sensitive to dopamine or to a series of structurally related agonists/antagonists of D1-and D2-like receptors (G. Dallerac & J.-P. Mothet, personal communication).…”
Section: Detecting D -Serine Properly With Analytical Methods: That Imentioning
confidence: 99%
“…D-Serine has also been found in endocrine organs, such as the adrenal and pituitary glands, pancreas, and testis, of rats [65, 66]. However, levels of D-serine in the endocrine system are much lower than those in the CNS, and the physiological role of D-serine in the endocrine systems remains unclear.…”
Section: D-serinementioning
confidence: 99%
“…D-Aspartate is found in the CNS of rodents and humans [16, 19, 6772] as well as in endocrine organs, including the pineal gland [69, 72, 73], pituitary gland [68, 69, 71, 72, 74], pancreas [66], adrenal gland [19, 67, 72, 74, 75], and testis, of rats [74, 76]. D-Aspartate activates NMDA receptors via binding to the agonist site of GluN2 subunits (2A–D) [7779] and can also activate metabotropic glutamate receptor 5 (mGlu5) [80].…”
Section: D-aspartatementioning
confidence: 99%